TP53 Y220C

PRINCETON, N.J., August 31, 2026 PMV Pharmaceuticals announced updated interim data from the Phase 2 pivotal portion of the...

PRINCETON, N.J., Aug. 14, 2026 PMV Pharmaceuticals, Inc. reported continued progress in its Phase 2 PYNNACLE clinical trial evaluating...